B

Brise Pharma

HealthPharmaceuticalsB2B📍 Beijing, China

Brise Pharma, a Beijing-based company, has entered into a discovery and commercialization deal with AbbVie for two preclinical migraine programs. This partnership aims to advance the development of novel treatments for migraine.

Total raised
Undisclosed
tracked to date
Latest round
up to $757M
Nov 2, 2026
Known investors
1
led by AbbVie

Is this your company?

Claim this profile to get matched with investors who fund Health startups in China.

Claim this profile →

Funding history

  1. 1
    up to $757MNov 2, 2026

    Led by AbbVie

    Announcement ↗

Investors in Brise Pharma

Backers from this company's tracked funding rounds.

  • AAbbVieLead investorVC firm

Brise Pharma in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile